Enabling Valve Therapies
The possibility of residual or recurrent regurgitation after mitral or tricuspid TEER poses significant challenges in clinical decision-making. The AMX Clip Removal System solves this dilemma across the entire disease spectrum by enabling a repair first mentality, and provides a solution for patients who later have disease progression.
Paul Sorajja, MD
Founder & Chief Medical Officer
Clinical Need
In the coming years, hundreds of thousands of patients will receive a Transcatheter Edge-to-Edge Repair (TEER) procedure to address Mitral Valve Regurgitation (MR) - a significant percentage of these patients will experience a return of MR to a level indicated for intervention. For those who receive TEER for Tricuspid Repair (TR), the risk of residual or recurrent regurgitation is even higher.
Unfortunately, patients with TEER failure are rarely surgical candidates due to high-risk, concomitant conditions, leaving the heart team with few or no options.
AMX Solution
The surgical predicate for treatment of atrioventricular valve disease is "repair-first". AMX extends this mentality into the interventional space.
The AMX Clip Removal Procedure uses a novel platform that is designed to safely remove edge-to-edge clips, giving interventionalist confidence that non-surgical options can now extend beyond this procedure.
